Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

A 4-year longitudinal study of 555 patients treated with ranibizumab for neovascular age-related macular degeneration

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Peripapillary Ovoid Hyperreflectivity in Optic Disc Edema and Pseudopapilledema

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Adrenal Suppression in Infants Treated with Topical Ocular Glucocorticoids

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Long-Term Metastatic Risk after Biopsy of Posterior Uveal Melanoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Myopic Choroidal Neovascularization: Review, Guidance, and Consensus Statement on Management

    Research output: Contribution to journalReviewResearchpeer-review

  5. Operating Room Performance Improves after Proficiency-Based Virtual Reality Cataract Surgery Training

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Loss of retinal tension and permanent decrease in retinal function: a new porcine model of rhegmatogenous retinal detachment

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Reply: Is automated screening for DR indeed not yet ready as stated by Grauslund et al?

    Research output: Contribution to journalLetterResearchpeer-review

  3. Spectral-domain optical coherence tomography of retinal vessels in Waldenström's macroglobulinemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Melanopsin-mediated pupillary light reflex and sleep quality in patients with normal tension glaucoma

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
To investigate the visual outcome, pattern of discontinuation, ocular complications, and mortality of patients treated with a variable ranibizumab dosing regimen for neovascular age-related macular degeneration (AMD) for 4 years.
Original languageEnglish
JournalOphthalmology
Volume120
Issue number12
Pages (from-to)2630-6
Number of pages7
ISSN0161-6420
DOIs
Publication statusPublished - Dec 2013

ID: 42459089